A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
The test, which is at least 12 times faster than current microbiological tests, is the result of research by Dr Nuno Reis, Lecturer in Chemical Engineering at Loughborough University, and Dr Al Edwards, Associate Professor in Biomedical Technology at the University of Reading. The full study has been published in the Lab on a Chip journal.
The study showed that dipstick tests routinely used for testing in a variety of scenarios from soil pH strips for the garden to pregnancy tests, could be updated using the latest approach in miniaturised testing technology to help form the basis of a new generation of advanced, yet affordable, point-of-care tests for global diagnostics.
As part of the study, different cellular tests were carried out to demonstrate the full potential of Lab-on-a-Stick devices for a range of clinical situations:
Anti-microbial resistance – this was measured with E. coli samples typical of common urinary tract infection (UTIs). UTIs can be hard to treat with antibiotics because antibiotic resistance is so common and lab testing takes at least two days. The assay detects antibiotic resistance – in other words, can the cells grow in the presence of the antibiotic, and how much antibiotic is needed to stop cell growth? This demonstrated the advantage of using the microcapillary film which enables 10 different concentrations of antibiotic per sample to be tested with a single test strip. The research team are currently optimising this so that the test, which currently requires overnight incubation in a multi-well plate, could in the future be completed in less than two hours in a single test strip.
Bacteria identification – classical analytical microbiology tests used for the identification of bacteria were miniaturised and performed in parallel microcapillaries, resulting in simple and rapid identification of bacteria. To identify bacteria, many different tests must be performed on every sample, illustrating again the benefits of microcapillary film which performs 10 tests per test strip. This study demonstrated a four-hour test to distinguish two very closely related bacteria – a harmless laboratory strain of E. coli from a type of Salmonella that causes food poisoning.
ABO blood typing – a simple blood test that takes only two minutes was miniaturised and the results were recorded using an everyday digital camera.
Dr Reis said: “This is a major step towards miniaturising complex, routine microbiological and clinical tests that cannot at the moment be performed outside of the laboratory setting.
“Our secret is simplicity. We have shown how microengineered film material made from a very transparent plastic with special optical properties, makes it easy to perform laboratory tests without lab equipment. Previously, we showed how a portable Lab-in-a-briefcase made it possible to record blood test results with the assistance of a simple smartphone.”
Dr Edwards, co-author of the study, said: “This is the latest demonstration of our exciting new technology called microcapillary film. Many researchers across the world have shown how miniaturising lab tests can speed them up using microfluidic Lab-on-a-Chip devices. But these are too expensive to be useful outside the laboratory. What we have done is to develop a low cost way of making thousands of miniature test tubes, so that we can use them for many important applications. Lab-on-a-Stick shows yet again how versatile these microscopic test tubes are.”
The Latest on: Microfluidic strip
via Google News
The Latest on: Microfluidic strip
- A Preanalytic Blood Separation and Metering System for Qualitative and Quantitative Lateral Flow Biosensorson November 21, 2021 at 4:00 pm
Cost/manufacturing Existing commercial available materials and avoiding sophisticated microfluidics. To determine if an analyte ... the blood sample must be transferred to a testing device (e.g., a ...
- LumiraDx Limited's (LMDX) CEO Ron Zwanziger On Q3 2021 Results - Earnings Call Transcripton November 10, 2021 at 12:01 pm
Our micro microfluidic technology and platform are ... COVID Antigen Pool test enables five samples to be processed on a single test strip, offering the same lab performance as our current Antigen ...
- LumiraDx receives approval for its COVID-19 Antigen Test for use in Indiaon October 20, 2021 at 5:21 am
The Platform consists of a small, portable instrument; microfluidic test strip; simple, standardized workflow; and seamless, secure digital connectivity to the cloud and hospital IT systems.
- LumiraDx receives approval for its COVID-19 Antigen Test for use in Indiaon October 20, 2021 at 4:12 am
The Platform consists of a small, portable instrument; microfluidic test strip; simple, standardized workflow; and seamless, secure digital connectivity to the cloud and hospital IT systems. The ...
via Bing News